Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clps (CLPS) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Clps (CLPS) over the last 9 years, with Q2 2025 value amounting to $28.2 million.

  • Clps' Cash & Equivalents fell 323.97% to $28.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $28.2 million, marking a year-over-year decrease of 323.97%. This contributed to the annual value of $28.2 million for FY2025, which is 323.97% down from last year.
  • As of Q2 2025, Clps' Cash & Equivalents stood at $28.2 million, which was down 323.97% from $35626.1 billion recorded in Q4 2024.
  • In the past 5 years, Clps' Cash & Equivalents ranged from a high of $35626.1 billion in Q4 2024 and a low of $18.4 million during Q2 2022
  • For the 5-year period, Clps' Cash & Equivalents averaged around $5089.5 billion, with its median value being $28.2 million (2025).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first crashed by 2563.68% in 2022, then soared by 10147322283.84% in 2024.
  • Clps' Cash & Equivalents (Quarter) stood at $24.7 million in 2021, then fell by 25.64% to $18.4 million in 2022, then surged by 90.84% to $35.1 million in 2023, then surged by 101473222.84% to $35626.1 billion in 2024, then tumbled by 100.0% to $28.2 million in 2025.
  • Its Cash & Equivalents stands at $28.2 million for Q2 2025, versus $35626.1 billion for Q4 2024 and $29.1 million for Q2 2024.